Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,831.00
-16.00 (-0.87%)
Aug 4, 2026, 11:11 AM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 48.24 billion as of August 3, 2026. Its market cap has increased by 41.88% in one year.
Market Cap
48.24B
Enterprise Value
66.98B
Revenue
57.30B
Ranking
n/a
PE Ratio
18.74
Stock Price
1,831.00
ChartMarket Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 48.24B, an increase of 177.51%. That is a compound annual growth rate of 5.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 48.24B | 4.49% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 169.33B |
| Kaken Pharmaceutical | 143.71B |
| Mochida Pharmaceutical | 110.51B |
| Zeria Pharmaceutical | 92.13B |
| KYORIN Pharmaceutical | 65.62B |
| ASKA Pharmaceutical Holdings | 61.08B |
| Daito Pharmaceutical | 36.02B |
| Koa Shoji Holdings | 32.73B |